Insider Trading April 3, 2026

Photronics SVP Disposes $420,831 of Stock; Transaction Filed With SEC

Senior operations executive sold 10,000 shares; company reports quarterly beat and equipment upgrade plans

By Avery Klein PLAB
Photronics SVP Disposes $420,831 of Stock; Transaction Filed With SEC
PLAB

Photronics INC (NASDAQ:PLAB) reported an insider sale on April 1, 2026, when SVP/COO IC & US/EU Mnstrm Ops Wang Hsueh-Chun sold 10,000 shares across three trades for a combined $420,831. The sale was disclosed on a Form 4 and leaves Wang with 154,685 shares. The transaction arrives as Photronics posts better-than-expected fiscal Q1 2026 results and outlines a Korea facility upgrade, while some analysis flags the stock as overvalued relative to its Fair Value despite a strong balance sheet.

Key Points

  • Wang Hsueh-Chun sold 10,000 Photronics shares on April 1, 2026, in three trades at $42.00 to $42.15 per share, totaling $420,831.
  • Photronics reported fiscal Q1 2026 EPS of $0.61 and revenue of $225.07 million, beating consensus estimates by 15.82% on EPS and 1.92% on revenue.
  • The company plans to install a new mask writer at its Korea facility in fiscal Q2 2026 to enhance AMOLED photomask production including G8.6 sizes; Craig-Hallum raised its price target to $48 from $42 and kept a Buy rating.

Photronics INC (NASDAQ:PLAB) disclosed an insider sale executed on April 1, 2026, when Senior Vice President and Chief Operating Officer for IC and US/EU Mainstream Operations Wang Hsueh-Chun sold 10,000 shares of common stock, according to a Form 4 filing with the Securities and Exchange Commission.

The disposals took place in three separate transactions at prices ranging from $42.00 to $42.15 per share, producing a total transaction value of $420,831. After these sales, Wang directly holds 154,685 shares of Photronics common stock.

At the time of reporting, Photronics shares were trading at $40.85, representing a 125% increase over the prior 12 months. Independent InvestingPro analysis cited in company materials indicates the stock appears overvalued relative to its Fair Value metric, while also assigning Photronics a "GOOD" financial health score driven by a balance sheet that contains more cash than debt. Investors are noted to have access to 12 additional InvestingPro Tips and a fuller slate of analysis for PLAB.


Separately, Photronics published fiscal first-quarter 2026 results that topped consensus estimates. The company delivered earnings per share of $0.61, versus an expected $0.5267, and generated revenue of $225.07 million compared with a forecast of $220.83 million. The EPS outcome represented a 15.82% surprise relative to expectations, while revenues exceeded estimates by 1.92%.

On the operational front, Photronics announced plans to install a new mask writer at its Korea facility. The company expects the equipment, which will support AMOLED photomask production including G8.6 sizes, to be implemented in fiscal second quarter 2026. Management said the installation is intended to improve mask-writing stability and accuracy.

In the analyst community, Craig-Hallum reiterated a Buy rating on Photronics shares while increasing its price target to $48 from $42. Craig-Hallum highlighted Photronics’ positioning as semiconductor manufacturers increasingly look to outsource photomask production, a dynamic the firm believes supports the company’s strategic outlook.


Taken together, the insider sale, recent earnings beat, planned capital equipment upgrade in Korea, and the analyst target increase compose the latest set of strategic and financial developments affecting Photronics. The Form 4 filing provides a clear public record of the SVP/COO’s transactions, while company results and operational plans offer contemporaneous context on business performance and near-term investments.

Risks

  • Stock valuation - InvestingPro analysis indicates PLAB appears overvalued relative to its Fair Value, which could affect investor expectations and share price dynamics.
  • Execution timing - The Korea mask writer installation is slated for fiscal Q2 2026; any delays or integration issues could impact anticipated improvements in mask-writing stability and accuracy.
  • Market sensitivity - Photronics’ positioning relies in part on semiconductor manufacturers’ decisions to outsource photomask production; shifts in that demand pattern could affect revenue outlooks.

More from Insider Trading

Amalgamated Financial EVP Sells $195K in Stock; Q4 2025 Revenue Tops Estimates Apr 3, 2026 Rambus CEO Executes $470K Stock Sale as Company Confirms Q4 Results and Product Rollout Apr 3, 2026 Apogee Therapeutics CMO Sells $466,619 in Stock as Company Raises Capital via Multiple Offerings Apr 3, 2026 Apogee Therapeutics CFO Disposes $170,020 in Shares Amid Strong Stock Rally Apr 3, 2026 Immunome CFO Disposes $1.4 Million in Stock; Exercises Options Apr 3, 2026